Literature DB >> 23699784

Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study.

Nina Rieckmann, Ian M Kronish, Peter A Shapiro, William Whang, Karina W Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23699784      PMCID： PMC3718306          DOI： 10.1001/jamainternmed.2013.910

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  7 in total

1.  Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.

Authors:  Karina W Davidson; Matthew M Burg; Ian M Kronish; Daichi Shimbo; Lucia Dettenborn; Roxana Mehran; David Vorchheimer; Lynn Clemow; Joseph E Schwartz; Francois Lespérance; Nina Rieckmann
Journal:  Arch Gen Psychiatry       Date:  2010-05

Review 2.  AAFP guideline for the detection and management of post-myocardial infarction depression.

Authors: 
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

3.  Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease.

Authors:  Carmine Pizzi; Anne Wilhelmina Saskia Rutjes; Grazia Maria Costa; Fiorella Fontana; Andrea Mezzetti; Lamberto Manzoli
Journal:  Am J Cardiol       Date:  2011-01-20       Impact factor: 2.778

Review 4.  Antidepressants and risk of upper gastrointestinal bleeding.

Authors:  Francisco J de Abajo; Dolores Montero; Luis A García Rodríguez; Mariano Madurga
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

5.  Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis.

Authors:  Marianna Mazza; Marzia Lotrionte; Giuseppe Biondi-Zoccai; Antonio Abbate; Imad Sheiban; Enrico Romagnoli
Journal:  J Psychopharmacol       Date:  2009-12-04       Impact factor: 4.153

Review 6.  Depression and related psychological factors in heart disease.

Authors:  Laura K Kent; Peter A Shapiro
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

7.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.

Authors:  Judith H Lichtman; J Thomas Bigger; James A Blumenthal; Nancy Frasure-Smith; Peter G Kaufmann; François Lespérance; Daniel B Mark; David S Sheps; C Barr Taylor; Erika Sivarajan Froelicher
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690
  7 in total
  18 in total

Review 1.  Management of depression after myocardial infarction.

Authors:  Peter A Shapiro
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

2.  Effects of long-term sertraline treatment and depression on coronary artery atherosclerosis in premenopausal female primates.

Authors:  Carol A Shively; Thomas C Register; Susan E Appt; Thomas B Clarkson
Journal:  Psychosom Med       Date:  2015-04       Impact factor: 4.312

3.  Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease.

Authors:  Sherry L Grace; Jose R Medina-Inojosa; Randal J Thomas; Heather Krause; Kristin S Vickers-Douglas; Brian A Palmer; Francisco Lopez-Jimenez
Journal:  Psychother Psychosom       Date:  2018-03-13       Impact factor: 17.659

Review 4.  The impact of treatment with selective serotonin reuptake inhibitors on primate cardiovascular disease, behavior, and neuroanatomy.

Authors:  Carol A Shively; Marnie Silverstein-Metzler; Jamie Justice; Stephanie L Willard
Journal:  Neurosci Biobehav Rev       Date:  2016-08-30       Impact factor: 8.989

5.  [Treatment of depression in coronary heart disease].

Authors:  A Agorastos; F Lederbogen; C Otte
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

6.  Long-term sertraline treatment and depression effects on carotid artery atherosclerosis in premenopausal female primates.

Authors:  Marnie G Silverstein-Metzler; Jamie N Justice; Susan E Appt; Leanne Groban; Dalane W Kitzman; John Jeffrey Carr; Thomas C Register; Carol A Shively
Journal:  Menopause       Date:  2017-10       Impact factor: 2.953

Review 7.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

8.  Association between major depression and cardiovascular risk: the role of antidepressant medication.

Authors:  Linn K Kuehl; Christoph Muhtz; Kim Hinkelmann; Lucia Dettenborn; Katja Wingenfeld; Carsten Spitzer; Christian Otte
Journal:  Psychopharmacology (Berl)       Date:  2016-07-27       Impact factor: 4.530

9.  Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.

Authors:  Jae-Min Kim; Robert Stewart; Yong-Seong Lee; Hee-Joon Lee; Min Chul Kim; Ju-Wan Kim; Hee-Ju Kang; Kyung-Yeol Bae; Sung-Wan Kim; Il-Seon Shin; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jin-Sang Yoon
Journal:  JAMA       Date:  2018-07-24       Impact factor: 56.272

10.  The effect of lifestyle modification on depression among myocardial infarction patients after revascularisation.

Authors:  Aminu Arzet; Wilbert Sibanda; D P Naidoo; Ponnusamy Somalingum
Journal:  Cardiovasc J Afr       Date:  2021-03-26       Impact factor: 1.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.